Top

Critical Care

Published in:

Open Access 01-08-2012 | Research

Free hemoglobin concentration in severe sepsis: methods of measurement and prediction of outcome

Authors: Michael Adamzik, Tim Hamburger, Frank Petrat, Jürgen Peters, Herbert de Groot, Matthias Hartmann

Published in: Critical Care | Issue 4/2012

Abstract

Introduction

Hemolysis can be induced in sepsis via various mechanisms, its pathophysiological importance has been demonstrated in experimental sepsis. However, no data on free hemoglobin concentrations in human sepsis are available. In the present study we measured free hemoglobin in patients with severe sepsis as well as in postoperative patients using four methods. It was our aim to determine the potential value of free hemoglobin as a biomarker for diagnosis and outcome of severe sepsis in critical illness.

Methods

Plasma concentration of free hemoglobin was determined in patients with severe sepsis (n = 161) and postoperative patients (n = 136) on day 1 of diagnosis and surgery. For the measurement of free hemoglobin, an enzyme linked immunosorbent assay and three spectrophotometric algorithms were used. Moreover, SAPS II- and SOFA scores as well as procalcitonin concentration and outcome were determined. Kaplan-Meier analysis was performed and odds ratios were determined after classification of free hemoglobin concentrations in a high and low concentration group according to the median. For statistical evaluation the Mann-Whitney test and logistic regression analysis were used.

Results

In non-survivors of severe sepsis, free hemoglobin concentration was twice the concentration compared to survivors. Thirty-day survival of patients, as evidenced by Kaplan-Meier analysis, was markedly lower in patients with high free hemoglobin concentration than in patients with low free hemoglobin concentration. Best discrimination of outcome was achieved with the spectrophotometric method of Harboe (51.3% vs. 86.4% survival, p < 0.001; odds ratio 6.1). Multivariate analysis including free hemoglobin, age, SAPS II- and SOFA-score and procalcitonin demonstrated that free hemoglobin, as determined by all 4 methods, was the best and an independent predictor for death in severe sepsis (p = 0.022 to p < 0.001). Free hemoglobin concentrations were not significantly different in postoperative and septic patients in three of four assays. Thus, free hemoglobin can not be used to diagnose severe sepsis in critical illness.

Conclusions

Free hemoglobin is an important new predictor of survival in severe sepsis.

Available only for authorised users

Christaki E, Opal SM: Is the mortality rate for septic shock really decreasing?. Curr Opin Crit Care. 2008, 14: 580-586. 10.1097/MCC.0b013e32830f1e25.PubMedCrossRef

Stearns-Kurosawa DJ, Osuchowski MF, Valentine C, Kurosawa S, Remick DG: The pathogenesis of sepsis. Annu Rev Pathol. 2011, 28: 19-48.CrossRef

Akira S, Uematsu S, Takeuchi O: Pathogen recognition and innate immunity. Cell. 2006, 124: 783-801. 10.1016/j.cell.2006.02.015.PubMedCrossRef

Zedler S, Faist E: The impact of endogenous triggers on trauma-associated inflammation. Curr Opin Crit Care. 2006, 12: 595-601. 10.1097/MCC.0b013e3280106806.PubMedCrossRef

Davis JH, Yull AB: The red blood cell: an essential component of the toxicity of strangulation intestinal obstruction. Proc Soc Exp Biol Med. 1961, 108: 252-253.PubMedCrossRef

Bloom O, Wang H, Ivanova S, Vishnubhakat JM, Ombrellino M, Tracey KJ: Hypophysectomy, high tumor necrosis factor levels, and hemoglobinemia in lethal endotoxemic shock. Shock. 1998, 10: 395-400. 10.1097/00024382-199812000-00003.PubMedCrossRef

Su D, Roth RI, Levin J: Hemoglobin infusion augments the tumor necrosis response to bacterial endotoxin (lipopolysaccharide) in mice. Crit Care Med. 1999, 28: 771-778.CrossRef

Larsen R, Gozzelino R, Jeney V, Tokaji L, Bozza FA, Japiassú AM, Bonaparte D, Cavalcante MM, Chora A, Ferreira A, Marguti I, Cardoso S, Sepúlveda N, Smith A, Soares MP: A central role for free heme in the pathogenesis of severe sepsis. Sci Transl Med. 2010, 2: 51ra71-10.1126/scitranslmed.3001118.PubMed

Sheu CC, Zhai R, Wang Z, Gong MN, Tejera P, Chen F, Su L, Thompson BT, Christiani DC: Hemeoxygenase-1 microsatellite polymorphism and haplotypes are associated with the development of acute respiratory distress syndrome. Intensive Care Med. 2009, 35: 1343-1351. 10.1007/s00134-009-1504-6.PubMedPubMedCentralCrossRef

10.

Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003, 31: 1250-1256. 10.1097/01.CCM.0000050454.01978.3B.PubMedCrossRef

11.

Le Gall JR, Lemeshow S, Saulnier F: A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA. 1993, 270: 2957-2963. 10.1001/jama.1993.03510240069035.PubMedCrossRef

12.

Ferreira FL, Bota DP, Bross A, Mélot C, Vincent JL: Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. 2001, 286: 1754-1758. 10.1001/jama.286.14.1754.PubMedCrossRef

13.

Harboe M: A method for determination of hemoglobin in plasma by near-ultraviolet spectrophotometry. Scand J Clin Lab Invest. 1959, 11: 66-70. 10.3109/00365515909060410.PubMedCrossRef

14.

Noe DA, Weedn V, Bell WR: Direct spectrophotometry of serum hemoglobin: an Allen correction compared with a three-wavelength polychromatic analysis. Clin Chem. 1984, 30: 627-630.PubMed

15.

Fairbanks VF, Ziesmer SC, O'Brien PC: Methods for measuring plasma hemoglobin in micromolar concentration compared. Clin Chem. 1992, 38: 132-140.PubMed

16.

Schaer DJ, Alayash AI: Clearance and control mechanisms of hemoglobin from cradle to grave. Antioxid Redox Signal. 2010, 12: 181-184. 10.1089/ars.2009.2923.PubMedCrossRef

17.

Huffman DL, Bischof LJ, Griffitts JS, Aroian RV: Pore worms: using Caenorhabditis elegans to study how bacterial toxins interact with their target host. Int J Med Microbiol. 2004, 293: 599-607. 10.1078/1438-4221-00303.PubMedCrossRef

18.

Aroian R, van der Goot FG: Pore-forming toxins and cellular nonimmune defenses (CNIDs). Curr Opin Microbiol. 2007, 10: 57-61. 10.1016/j.mib.2006.12.008.PubMedCrossRef

19.

Gonzalez MR, Bischofberger M, Pernot L, van der Goot FG, Freche B: Bacterial pore-forming toxins: the (w)hole story?. Cell Mol Life Sci. 2008, 65: 493-507. 10.1007/s00018-007-7434-y.PubMedCrossRef

20.

Bull BS, Kuhn IN: The production of schistocytes by fibrin strands (a scanning electron microscope study). Blood. 1970, 35: 104-111.PubMed

21.

Heyes H, Köhle W, Slijepcevic B: The appearance of schistocytes in the peripheral blood in correlation to the degree of disseminated intravascular coagulation. An experimental study in rats. Haemostasis. 1976, 5: 66-73.PubMed

22.

Ehrnthaller C, Ignatius A, Gebhard F, Huber-Lang M: New insights of an old defense system: structure, function, and clinical relevance of the complement system. Mol Med. 2011, 17: 317-329.PubMedPubMedCentralCrossRef

23.

Pöschl JM, Leray C, Ruef P, Cazenave JP, Linderkamp O: Endotoxin binding to erythrocyte membrane and erythrocyte deformability in human sepsis and in vitro. Crit Care Med. 2003, 31: 924-928. 10.1097/01.CCM.0000055366.24147.80.PubMedCrossRef

24.

Lang F, Gulbins E, Lang PA, Zappulla D, Föller M: Ceramide in suicidal death of erythrocytes. Cell Physiol Biochem. 2010, 26: 21-28. 10.1159/000315102.PubMedCrossRef

25.

Hod EA, Zhang N, Sokol SA, Wojczyk BS, Francis RO, Ansaldi D, Francis KP, Della-Latta P, Whittier S, Sheth S, Hendrickson JE, Zimring JC, Brittenham GM, Spitalnik SL: Transfusion of red blood cells after prolonged storage produces harmful effects that are mediated by iron and inflammation. Blood. 2010, 115: 4284-4292. 10.1182/blood-2009-10-245001.PubMedPubMedCentralCrossRef

26.

Bornside GH, Bouis PJ, Cohn I: Hemoglobin and Escherichia coli, a lethal intraperitoneal combination. J Bacteriol. 1968, 95: 1567-1571.PubMedPubMedCentral

27.

Kaca W, Roth RI, Levin J: Hemoglobin, a newly recognized lipopolysaccharide (LPS)-binding protein that enhances LPS biological activity. J Biol Chem. 1994, 269: 25078-25084.PubMed

28.

Roth RI, Kaca W, Levin J: Hemoglobin: a newly recognized binding protein for bacterial endotoxins (LPS). Prog Clin Biol Res. 1994, 388: 161-172.PubMed

29.

Lin T, Kwak YH, Sammy F, He P, Thundivalappil S, Sun G, Chao W, Warren HS: Synergistic inflammation is induced by blood degradation products with microbial Toll-like receptor agonists and is blocked by hemopexin. J Infect Dis. 2010, 202: 624-632. 10.1086/654929.PubMedPubMedCentralCrossRef

30.

Weinberg JA, Barnum SR, Patel RP: Red blood cell age and potentiation of transfusion-related pathology in trauma patients. Transfusion. 2011, 51: 867-873. 10.1111/j.1537-2995.2011.03098.x.PubMedPubMedCentralCrossRef

31.

Belcher JD, Beckman JD, Balla G, Balla J, Vercellotti G: Heme degradation and vascular injury. Antioxid Redox Signal. 2010, 12: 233-248. 10.1089/ars.2009.2822.PubMedPubMedCentralCrossRef

32.

Pishchany G, McCoy AL, Torres VJ, Krause JC, Crowe JE, Fabry ME, Skaar EP: Specificity for human hemoglobin enhances Staphylococcus aureus infection. Cell Host Microbe. 2010, 8: 544-550. 10.1016/j.chom.2010.11.002.PubMedPubMedCentralCrossRef

33.

Tullius MV, Harmston CA, Owens CP, Chim N, Morse RP, McMath LM, Iniguez A, Kimmey JM, Sawaya MR, Whitelegge JP, Horwitz MA, Goulding CW: Discovery and characterization of a unique mycobacterial heme acquisition system. Proc Natl Acad Sci USA. 2011, 108: 5051-5056. 10.1073/pnas.1009516108.PubMedPubMedCentralCrossRef

34.

Nieuwland R, Berckmans RJ, McGregor S, Böing AN, Romijn FP, Westendorp RG, Hack CE, Sturk A: Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood. 2000, 95: 930-935.PubMed

35.

Figueiredo RT, Fernandez PL, Mourao-Sa DS, Porto BN, Dutra FF, Alves LS, Oliveira MF, Oliveira PL, Graça-Souza AV, Bozza MT: Characterization of heme as activator of Toll-like receptor 4. J Biol Chem. 2007, 282: 20221-20229. 10.1074/jbc.M610737200.PubMedCrossRef

36.

Silva G, Jeney V, Chora A, Larsen R, Balla J, Soares MP: Oxidized hemoglobin is an endogenous proinflammatory agonist that targets vascular endothelial cells. J Biol Chem. 2009, 284: 29582-29595. 10.1074/jbc.M109.045344.PubMedPubMedCentralCrossRef

37.

Fernandez PL, Dutra FF, Alves L, Figueiredo RT, Mourão-Sa D, Fortes GB, Bergstrand S, Lönn D, Cevallos RR, Pereira RM, Lopes UG, Travassos LH, Paiva CN, Bozza MT: Heme amplifies the innate immune response to microbial molecules through spleen tyrosine kinase (Syk)-dependent reactive oxygen species generation. J Biol Chem. 2010, 285: 32844-32851. 10.1074/jbc.M110.146076.PubMedPubMedCentralCrossRef

38.

Gozzelino R, Jeney V, Soares MP: Mechanisms of cell protection by heme oxygenase-1. Annu Rev Pharmacol Toxicol. 2010, 50: 323-354. 10.1146/annurev.pharmtox.010909.105600.PubMedCrossRef

Title: Free hemoglobin concentration in severe sepsis: methods of measurement and prediction of outcome
Authors: Michael Adamzik
Tim Hamburger
Frank Petrat
Jürgen Peters
Herbert de Groot
Matthias Hartmann
Publication date: 01-08-2012
Publisher: BioMed Central
Published in: Critical Care / Issue 4/2012
Electronic ISSN: 1364-8535
DOI: https://doi.org/10.1186/cc11425

At a glance: The STEP trials

Springer Medicine

Free hemoglobin concentration in severe sepsis: methods of measurement and prediction of outcome

Abstract

Introduction

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Introduction

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 4/2012

The confusion assessment method for the intensive care unit (CAM-ICU) and intensive care delirium screening checklist (ICDSC) for the diagnosis of delirium: a systematic review and meta-analysis of clinical studies

Impact of nystatin on Candida and the oral microbiome

A perioperative infusion of sodium bicarbonate does not improve renal function in cardiac surgery patients: a prospective observational cohort study

Identification of haplotype tag single nucleotide polymorphisms within the receptor for advanced glycation end products gene and their clinical relevance in patients with major trauma

Clinical review: Serious adverse events associated with the use of rituximab - a critical care perspective

The impact of statin use on pneumonia risk and outcome: a combined population-based case-control and cohort study